Celsion Corporation (CLSN): Price and Financial Metrics
Celsion Corporation (CLSN)
Today's Latest Price: $0.87 USD
Updated Jan 15 4:00pm
Add CLSN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
CLSN Stock Summary
- CLSN's price/sales ratio is 67.35; that's higher than the P/S ratio of 95.53% of US stocks.
- In terms of volatility of its share price, CLSN is more volatile than 98.12% of stocks we're observing.
- Celsion CORP's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -81.64%, greater than the shareholder yield of merely 3.37% of stocks in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to Celsion CORP are RGLS, XFOR, ARDX, RMBS, and PTCT.
- Visit CLSN's SEC page to see the company's official filings. To visit the company's web site, go to www.celsion.com.
CLSN Stock Price Chart Interactive Chart >
CLSN Price/Volume Stats
| Current price | $0.87 | 52-week high | $6.50 |
| Prev. close | $0.90 | 52-week low | $0.43 |
| Day low | $0.85 | Volume | 3,060,800 |
| Day high | $0.92 | Avg. volume | 4,829,590 |
| 50-day MA | $0.66 | Dividend yield | N/A |
| 200-day MA | $1.35 | Market Cap | 32.55M |
Celsion Corporation (CLSN) Company Bio
Celsion Corporation focuses on the development and commercialization of directed chemotherapy, DNA-mediated immunotherapy, and RNA based therapy products for the treatment of cancer. The company was founded in 1982 and is based in Lawrenceville, New Jersey.
Loading social stream, please wait...